SUMMARY Mouse calvaria were maintained in organ culture without serum additives. The effects of Cu2+ on bone resorption and on the synthesis and action of prostaglandins were studied.
PGF2a production at the expense of PGE2." Prostaglandins, particularly those of the E series and the F series, are known to stimulate bone resorption in vitro,12 and the prostaglandin synthetase system has been identified in cultured bone. '3 The following study examines the possibility that the decreased bone resorption observed in the mouse calvarium in the presence of copper in vitro is associated with altered prostaglandin biosynthesis or action.
Material and methods

ORGAN CULTURE OF BONE
The organ culture procedure has been described in detail.in 14 Unless otherwise stated, calvaria were dissected from six-day old mice and then pooled and randomised into treatment groups and one control group. The bones were cultured singly in 5 ml Gibco 841 199 medium (without serum additives) and incubated in an atmosphere of 20% 02, 5% C02, and 75% N2. Calvaria were precultured for 24 h after dissection and then cultured in fresh medium for a further 48 h under experimental conditions. This procedure removes the large quantities of prostaglandins released after dissection and renders the system sensitive to stimulators of resorption. 14 Indomethacin and prostaglandins were added to the culture medium in absolute ethanol solutions. The alcohol added to both control and treated bones did not exceed a final concentration of 0-3% and as such had no effect on active resorption.
DETERMINATION OF ACTIVE RESORPTION
Resorption of bone was determined by the release of 45Ca into the medium from calvaria obtained from mice which were prelabelled with 5 ,uCi 45 CaC12 at 2 days of age. Non-cell-mediated release of 45Ca was determined from four calvaria of each litter, which were killed by triple freezing and thawing prior to incubation. The percentage active resorption (45Ca) was quantified and calculated as described.'0
MEASUREMENT OF PROSTAGLANDINS
The culture medium was sampled to determine 45Ca release and then acidified (pH 3.0) prior to extraction of the prostanoids. Prostaglandin F (PGF), prostaglandin E2 (PGE2), and 6-keto-prostaglandin Fla (6-keto-PGFla) were measured by specific radioimmunoassays. The method of extraction, assay procedures and cross-reactivity data for PGF and PGE2 radioimmunoassays have been described in detail. 14 15 Extraction with ethyl acetate improved the recovery of 6-keto-PGFia, and was therefore used in preference to diethyl ether when this prostanoid was assayed. An antiserum to 6-ketoPGFia conjugated with bovine serum albumin (BSA) was raised in rabbits. This antiserum crossreacted 14.7% with PGD2, 9.3% with PGF2a, 8-4% with PGE2, and 22*9% with 13, 14-dihydroPGF2a. ' Cu2+ (5 ,uM) did not appear selectively to enhance the production of any one of the prostaglandins measured ( Table 1 ). The addition of arachidonic acid (1O-5 M) to calvaria caused increased production of both PGF and PGE2 compared with the amounts released from calvaria cultured without arachidonic acid. This increase in PGF and PGE2 was concomitant with a rise in active resorption.'4 When calvaria were cultured with arachidonic acid in the presence of Cu2 , active resorption was significantly lowered, while PGF production increased above that seen with arachidonic acid alone (p<0-001), and PGE2 levels were not significantly different ( Table 2) .
The results obtained by radioimmunoassay measurements (Tables 1 and 2) Calvaria were precultured for 24 h, the medium changed, and prostaglandins added with or without Cu2+ (5 gM).
Percentage active resorption (45Ca) is expressed as mean ± SEM. Significant differences between each treatment and its appropriate control are shown on right hand side. Calvaria from two litters were pooled (n=5 each treatment). A = Difference. Table 4 compare the ability of PGE2 at each concentration to increase resorption under these conditions. As can be seen, the reduced resorption in the presence of Cu2+ cannot be overcome by increasing concentrations of PGE2. Arachidonic acid (10-5 M) or a higher concentration of PGE2 (10-5 M) or PGF2c, (10-5 M) were also unable to reverse the effect of Cu2+ (Table 5) .
Calvaria were cultured with or without Cu2+ with the addition of indomethacin at a concentration (7-Ox10-7 M) sufficient to inhibit prostaglandin synthesis.17 Cu2+ decreased the 45Ca resorption to 77-4% of that seen with indomethacin alone (p<0-05, n=5).
Discussion
A number of studies have confirmed that prostaglandins, particularly those of the E series and F series, and prostacyclin are potent stimulators of bone resorption in vitro.12 20 Mouse calvaria produce prostaglandins under appropriate culture conditions.13 14 Our own studies would indicate the involvement of these compounds in maintaining basal bone resorption in vitro, since non-toxic concentrations of indomethacin (<=7-Ox 1-7 M) decreased both bone resorption and prostaglandin production. The possibility that copper was affecting the action of prostaglandins on bone resorption was also considered. Arachidonic acid (10-5 M) increased both prostaglandin production and active resorption ( Table 2 ). This arachidonic acid-stimulated resorption was significantly reduced in the presence of Cu2+ (Table 5 ) despite an increase in PGF production (Table 2) , that is, the production of prostaglandins was increased, but their action was inhibited by Cu2+. This observation was confirmed when either PGE2 or PGF2a was added to Cu2+. Increasing concentrations of PGE2 (10-8 M to i0-5 M) and high concentrations of PGF2a (10-5 M) were unable to reverse the inhibition of resorption caused by Cu2+ (Tables 4 and 5) .
These results suggest that Cu2+ may 'uncouple' the resorptive response to prostaglandins, but its exact mechanism of action cannot be deduced from these experiments. It is likely that Cu2' has more than one locus of action. This was suggested by experiments where calvaria were cultured with indomethacin (7-Ox 10-7 M) with and without Cu2+ (5 ,uM This study does not suggest any simple interpretation of the action of copper as an anti-inflammatory agent in inflammatory diseases such as rheumatoid arthritis, ankylosing spondylitis, and periodontal disease. It gives some indication of the need for care in devising experimental models for these conditions, since the possibility of an anti-inflammatory (or antiresorptive activity) of copper in opposing prostaglandin action rather than synthesis has not always been considered.23 Thus the high concentrations of both prostaglandins24 25 and CU2+ 26 in rheumatoid arthritis synovial fluid cannot necess-~~~~~2 arily boe interpreted as suggesting that Cu2+ has no anti-inflammatory activity.
In summary, the mechanism of action of Cu2+ in decreasing bone resorption appears complex. Evidence has been presented to show that the release of prostaglandins is not reduced, but rather enhanced, possibly due to a non-specific effect on the activity of cyclooxygenase. It would appear that Cu2+ not only impedes the action of exogenous prostaglandins on bone but may also inhibit resorption mediated by lysosomal enzymes or other as yet undefined mechanisms. 
